Monday , December 23 2024
Home / Media OutReach / Exotic Currency Addition: OctaFX Includes Mexican Peso in its asset Pool

Exotic Currency Addition: OctaFX Includes Mexican Peso in its asset Pool

KUALA LUMPUR, MALAYSIA – Media OutReach – 3 September 2021 – The Mexican peso (MXN) enters OctaFX‘s currency pool at the end of August—it comes with three tradable currency pairs.

 

Finally, the most traded currency from Latin America enters global Forex broker OctaFX’s ensemble—the Mexican peso (MXN).

 

Being the third-largest currency traded in North America (after the U.S. dollar and Canadian dollar), the Mexican currency is issued and governed by a nation with the 15th largest nominal gross domestic product (GDP) of an equivalent of well over one trillion U.S. dollars.

So there is an evident and reasonable long-term play here not to neglect the Mexican peso all the more.

 

Many factors make Mexico an attractive financial hub in the world. Manufactured goods for export and tourism, as well as inward capital flow from Mexican nationals working abroad have been the chief sources of foreign income for the federal republic. With its over 126 million inhabitants, the country has a bit over a third the population of the United States and sets out to potentially be the fifth-largest economy in the world in the decades to come.

 

The international fintech company starts off its most recent novelty surrounding the Mexican peso with the following three currency pairs:

●      USDMXN (U.S. dollar/Mexican peso)

●      EURMXN (euro/Mexican peso)

●      GBPMXN  (Great Britain pound/Mexican peso)

According to OctaFX’s assessments, these specifically added currency pairs provide clients with a more diverse, convenient, and up-to-date trading experience.

 

Due to the decade-strong resilience of Mexico’s economy and growing numbers in foreign investment, the currency has solidified its position among the ranks of the fifteen most traded currency units globally.


Source link

About admin

Check Also

GangaGen Secures additional US$7.9 Million from CARB-X for Pre-clinical Development of Novel Klebicins Targeting Nosocomial Pneumonia caused by Multidrug-resistant Klebsiella pneumoniae

BANGALORE, INDIA / SINGAPORE – Media OutReach Newswire – 23 December 2024 – GangaGen announced …

Leave a Reply

Your email address will not be published.